|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000854,
umls-concept:C0008976,
umls-concept:C0040808,
umls-concept:C0070166,
umls-concept:C0178602,
umls-concept:C0205253,
umls-concept:C0442027,
umls-concept:C0595454,
umls-concept:C1274040,
umls-concept:C1280500,
umls-concept:C1707391,
umls-concept:C1708715,
umls-concept:C2346689,
umls-concept:C2348535
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2005-11-8
|
|
pubmed:abstractText |
For patients undergoing percutaneous coronary intervention, the administration of a clopidogrel loading dose ranging from 300 to 600 mg is currently recommended. It is unknown, though, whether loading doses higher than 600 mg exert additional suppression of platelet function.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
8
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2946-50
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16260639-Administration, Oral,
pubmed-meshheading:16260639-Aged,
pubmed-meshheading:16260639-Coronary Disease,
pubmed-meshheading:16260639-Dose-Response Relationship, Drug,
pubmed-meshheading:16260639-Double-Blind Method,
pubmed-meshheading:16260639-Female,
pubmed-meshheading:16260639-Humans,
pubmed-meshheading:16260639-Intestinal Absorption,
pubmed-meshheading:16260639-Male,
pubmed-meshheading:16260639-Middle Aged,
pubmed-meshheading:16260639-Platelet Aggregation,
pubmed-meshheading:16260639-Platelet Aggregation Inhibitors,
pubmed-meshheading:16260639-Platelet Count,
pubmed-meshheading:16260639-Stents,
pubmed-meshheading:16260639-Ticlopidine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.
|
|
pubmed:affiliation |
Deutsches Herzzentrum, Technische Universität München, Munich, Germany. beckerath@dhn.mhn.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
